4.7 Article

The pleiotropic movement disorders phenotype of adult ataxia-telangiectasia

期刊

NEUROLOGY
卷 83, 期 12, 页码 1087-1095

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000000794

关键词

-

资金

  1. French AT-Europe Foundation

向作者/读者索取更多资源

Objective:To assess the clinical spectrum of ataxia-telangiectasia (A-T) in adults, with a focus on movement disorders.Methods:A total of 14 consecutive adults with A-T were included at 2 tertiary adult movement disorders centers and compared to 53 typical patients with A-T. Clinical evaluation, neurophysiologic and video-oculographic recording, imaging, laboratory investigations, and ATM analysis were performed.Results:In comparison with typical A-T cases, our patients demonstrated later mean age at onset (6.1 vs 2.5 years, p < 0.0001), later loss of walking ability (p = 0.003), and longer survival (p = 0.0039). The presenting feature was ataxia in 71% and dysarthria and dystonia in 14% each. All patients displayed movement disorders, among which dystonia and subcortical myoclonus were the most common (86%), followed by tremor (43%). Video-oculographic recordings revealed mostly dysmetric saccades and 46% of patients had normal latencies (i.e., no oculomotor apraxia) and velocities. The -fetoprotein (AFP) level was normal in 7%, chromosomal instability was found in 29% (vs 100% of typical patients, p = 0.0006), and immunoglobulin deficiency was found in 29% (vs 69%, p = 0.057). All patients exhibited 2 ATM mutations, including at least 1 missense mutation in 79% of them (vs 36%, p = 0.0067).Conclusion:There is great variability of phenotype and severity in A-T, including a wide spectrum of movement disorders. Karyotype and repeated AFP level assessments should be performed in adults with unexplained movement disorders as valuable clues towards the diagnosis. In case of a compatible phenotype, A-T should be considered even if age at onset is late and progression is slow.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Implementation of a Magnetic Resonance Imaging scanner dedicated to emergencies in cases of binocular diplopia: Impact on patient management

Marie Stoessel, Francois Lersy, Mylene Moris, Guillaume Bierry, Mathieu Anheim, Stephane Kremer, Sabrina Garnier-Kepka

Summary: This study evaluated the implementation of a dedicated MRI scanner for the management of patients with binocular diplopia in the emergency department. The results showed that the use of the MRI scanner improved the diagnostic performance of binocular diplopia and reduced patient's exposure to ionizing radiation without increasing turnaround time or emergency department length of stay.

JOURNAL OF NEURORADIOLOGY (2023)

Article Surgery

Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma

Pascale Mariani, Francois-Clement Bidard, Aurore Rampanou, Alexandre Houy, Vincent Servois, Toulsie Ramtohul, Gaelle Pierron, Marion Chevrier, Benjamin Renouf, Olivier Lantz, Sophie Gardrat, Anne Vincent-Salomon, Sergio Roman-Roman, Manuel Rodrigues, Sophie Piperno-Neumann, Nathalie Cassoux, Marc-Henri Stern, Shufang Renault

Summary: This study reports the detection rate and prognostic impact of circulating tumor DNA in patients undergoing surgical resection of liver metastases in uveal melanoma. If confirmed by further studies, this noninvasive biomarker could inform treatment decisions for liver metastases in uveal melanoma patients.

ANNALS OF SURGERY (2023)

Meeting Abstract Oncology

DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION

D. Rombaut, C. Lefevre, B. Farhat, S. Bondu, A. Letessier, A. Lesieur-Pasquier, D. Castillo-Guzman, M. Leduc, S. Hartono, V. Chesnais, R. Mangione, I. Boussaid, A. Houy, D. Bouscary, L. Willems, N. Chapuis, O. Kosmider, S. Park, S. Raynaud, T. Cluzeau, E. Clappier, P. Fenaux, L. Ades, R. Margueron, M. Wassef, S. Alsafadi, E. Solary, A. Constantinou, M. -H. Stern, B. Palancade, N. Droin, B. Miotto, F. Chedin, M. Fontenay

LEUKEMIA RESEARCH (2023)

Article Multidisciplinary Sciences

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers

Petra ter Brugge, Sarah C. Moser, Ivan Bieche, Petra Kristel, Sabrina Ibadioune, Alexandre Eeckhoutte, Roebi de Bruijn, Eline van der Burg, Catrin Lutz, Stefano Annunziato, Julian de Ruiter, Julien Masliah Planchon, Sophie Vacher, Laura Courtois, Rania El-Botty, Ahmed Dahmani, Elodie Montaudon, Ludivine Morisset, Laura Sourd, Lea Huguet, Heloise Derrien, Fariba Nemati, Sophie Chateau-Joubert, Thibaut Larcher, Anne Salomon, Didier Decaudin, Fabien Reyal, Florence Coussy, Tatiana Popova, Jelle Wesseling, Marc-Henri Stern, Jos Jonkers, Elisabetta Marangoni

Summary: This study demonstrates that shallow HRD can predict the response to platinum-based chemotherapy in TNBC using patient-derived xenografts. Existing methods to identify HRD are controversial, and there is a medical need for predictive biomarkers. Evaluating the response to platinum agents in 55 TNBC patient-derived xenografts, the study found that the HRD status determined from whole genome sequencing can highly predict the response to platinum. Mutations in XRCC3 and ORC1 genes were also found to drive cisplatin response.

NATURE COMMUNICATIONS (2023)

Review Clinical Neurology

Scoping Review on ADCY5-Related Movement Disorders

Poornima Jayadev Menon, Christelle Nilles, Laura Silveira-Moriyama, Ruiyi Yuan, Claudio M. de Gusmao, Alexander Muenchau, Miryam Carecchio, Steve Grossman, Gay Grossman, Aurelie Meneret, Emmanuel Roze, Tamara Pringsheim

Summary: This scoping review summarizes the available clinical literature on ADCY5-RMD. Patients with ADCY5-RMD experience permanent and/or paroxysmal hyperkinetic movements, which can be worsened by environmental triggers. Treatment options are limited, but caffeine, benzodiazepines, and deep brain stimulation have shown some effectiveness.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Non-Motor Symptoms and Quality of Life in Patients with PRRT2-Related Paroxysmal Kinesigenic Dyskinesia

Asya Ekmen, Mohamed Doulazmi, Aurelie Meneret, Prasanthi Jegatheesan, Anais Herve, Philippe Damier, Domitille Gras, Agathe Roubertie, Juliette Piard, Eugenie Mutez, Clement Tarrano, Quentin Welniarz, Marie Vidailhet, Yulia Worbe, Cecile Gallea, Emmanuel Roze

Summary: This study investigated the relationship between non-motor symptoms and health-related quality of life (HrQoL) in PKD patients caused by monoallelic pathogenic variants of PRRT2. The study found that non-motor manifestations were an important determinant of HrQoL and patients also experienced higher levels of self-esteem and stigmatization. The results have important implications for patient management and medical education about PKD.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Oncology

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases

Pascale Mariani, Nouritza Torossian, Steven van Laere, Peter Vermeulen, Leanne de Koning, Sergio Roman-Roman, Olivier Lantz, Manuel Rodrigues, Marc-Henri Stern, Sophie Gardrat, Laetitia Lesage, Gabriel Champenois, Andre Nicolas, Alexandre Matet, Nathalie Cassoux, Vincent Servois, Emanuela Romano, Sophie Piperno-Neumann, Claire Lugassy, Raymond Barnhill

Summary: This study investigated the immune cell infiltrates in uveal melanoma liver metastases (UMLM) and found that CD68+ and CD163+ tumor-infiltrating macrophages, CD20+ peritumoral lymphocytes, and growth patterns were important prognostic factors.

BRITISH JOURNAL OF CANCER (2023)

Article Genetics & Heredity

Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees

Mathias Schwartz, Sabrina Ibadioune, Albain Chansavang, Sophie Vacher, Sandrine M. Caputo, Helene Delhomelle, Jennifer Wong, Khadija Abidallah, Virginie Moncoutier, Veronique Becette, Tatiana Popova, Voreak Suybeng, Antoine De Pauw, Marc-Henri Stern, Chrystelle Colas, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Lisa Golmard, Ivan Bieche, Julien Masliah-Planchon

Summary: Mosaic BRCA1 promoter methylation is associated with an increased risk of early-onset breast cancer, triple-negative breast cancer, and ovarian cancer. This de novo event could contribute to hereditary breast/ovarian cancer pedigrees, especially in families with affected relatives showing high prevalence of BRCA1meth. Detection of BRCA1meth may indicate involvement of BRCA1 in tumorigenesis in affected probands.

JOURNAL OF MEDICAL GENETICS (2023)

Article Genetics & Heredity

SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response

Philip Bland, Harry Saville, Patty T. Wai, Lucinda Curnow, Gareth Muirhead, Jadwiga Nieminuszczy, Nivedita Ravindran, Marie Beatrix John, Somaieh Hedayat, Holly E. Barker, James Wright, Lu Yu, Ioanna Mavrommati, Abigail Read, Barrie Peck, Mark Allen, Patrycja Gazinska, Helen N. Pemberton, Aditi Gulati, Sarah Nash, Farzana Noor, Naomi Guppy, Ioannis Roxanis, Guy Pratt, Ceri Oldreive, Tatjana Stankovic, Samantha Barlow, Helen Kalirai, Sarah E. Coupland, Ronan Broderick, Samar Alsafadi, Alexandre Houy, Marc-Henri Stern, Stephen Pettit, Jyoti S. Choudhary, Syed Haider, Wojciech Niedzwiedz, Christopher J. Lord, Rachael Natrajan

Summary: SF3B1 mutations confer sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPi). Mechanistically, this is independent of homologous recombination repair and instead relies on a defective replication stress response due to a reduction of the cyclin-dependent kinase 2 interacting protein (CINP). PARPi treatment of SF3B1 mutant (SF3B1(MUT)) tumors leads to replication stress induced by increased fork origin firing and culminates in cell cycle stalling. SF3B1 hotspot mutations are associated with a poor prognosis in several tumor types and lead to global disruption of canonical splicing.

NATURE GENETICS (2023)

Article Cell Biology

Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma

David Gentien, Elnaz Saberi-Ansari, Nicolas Servant, Ariane Jolly, Pierre de la Grange, Fariba Nemati, Geraldine Liot, Simon Saule, Aurelie Teissandier, Deborah Bourc'his, Elodie Girard, Jennifer Wong, Julien Masliah-Planchon, Erkan Narmanli, Yuanlong Liu, Emma Torun, Rebecca Goulancourt, Manuel Rodrigues, Laure Villoing Gaude, Cecile Reyes, Mateo Bazire, Thomas Chenegros, Emilie Henry, Audrey Rapinat, Mylene Bohec, Sylvain Baulande, Radhia M'kacher, Eric Jeandidier, Andre Nicolas, Giovanni Ciriello, Raphael Margueron, Didier Decaudin, Nathalie Cassoux, Sophie Piperno-Neumann, Marc-Henri Stern, Johan Harmen Gibcus, Job Dekker, Edith Heard, Sergio Roman-Roman, Joshua J. Waterfall

Summary: Through comprehensive multi-omics characterization, we identified genomic instability as a hallmark of uveal melanoma (UM) and confirmed the recurrent deletion in the BAP1 promoter associated with high risk of metastasis in UM patients. We also discovered the upregulation of PRAME as an independent prognostic biomarker and a potential therapeutic target in UM.

CELL REPORTS (2023)

Article Hematology

Impact of Graft Function on Health Status and Quality of Life in Very Long-Term Survivors Who Received an HSCT for Inborn Errors of Immunity, a Prospective Study of the CEREDIH

Audrey Petit, Benedicte Neven, Victoria Min, Nizar Mahlaoui, Despina Moshous, Martin Castelle, Maya Allouche, Arthur Sterin, Sandrine Visentin, Paul Saultier, Mohamed Boucekine, Alaa Mustafa Shawket, Capucine Picard, Pascal Auquier, Gerard Michel, Alain Fischer, Vincent Barlogis

Summary: The survival rate after hematopoietic stem cell transplantation for inborn errors of immunity has improved considerably, but many patients still experience poor health status and impaired quality of life. Abnormal graft function and chronic graft-versus-host disease are correlated with poor health and very poor health, which in turn directly affect the patients' HRQoL. Further studies are needed to examine the long-term impact of transplant procedure improvements on health status and HRQoL.

TRANSPLANTATION AND CELLULAR THERAPY (2023)

Meeting Abstract Oncology

Mutations in the RNA Splicing Factor SF3B1 drive endocrine therapy resistance and confer a targetable replication stress response defect through PARP inhibition

Phil Bland, Harry Saville, Abigail Read, Patty Wai, Gareth Muirhead, Lucinda Curnow, Jadwiga Nieminuszczy, Nivedita Ravindran, Marie John, Somaieh Hedayat, Holly Barker, James Wright, Lu Yu, Ioanna Mavrommati, Barrie Peck, Mark Allen, Patrycja Gazinska, Helen Pemberton, Aditi Gulati, Sarah Nash, Farzana Noor, Naomi Guppy, Ioannis Roxanis, Samantha Barlow, Helen Kalirai, Sarah Coupland, Ronan Broderick, Samar Alsafadi, Alexandre Houy, Marc-Henri Stern, Stephen Pettit, Jyoti Choudhary, Syed Haider, Wojciech Niedzwiedz, Christopher Lord, Rachael Natrajan

CANCER RESEARCH (2023)

Article Ophthalmology

In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity

Sen Ma, Ruben V. Huis In't Veld, Alexander Houy, Marc-Henri Stern, Cadmus Rich, Ferry A. Ossendorp, Martine J. Jager

Summary: The virus-like drug conjugate AU-011 shows potential in inducing immunogenic cell death in uveal melanoma cell lines, which may lead to systemic immune responses and suggests its potential for combination with immunotherapy.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2023)

Article Oncology

Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants

Marie-Charlotte Villy, Anais Le Ven, Marine Le Mentec, Julien Masliah-Planchon, Alexandre Houy, Ivan Bieche, Sophie Vacher, Anne Vincent-Salomon, Catherine Dubois d'Enghien, Mathias Schwartz, Sophie Piperno-Neumann, Alexandre Matet, Denis Malaise, Virginie Bubien, Alain Lortholary, Amal Ait Omar, Mathias Cavaille, Dominique Stoppa-Lyonnet, Nathalie Cassoux, Marc-Henri Stern, Manuel Rodrigues, Lisa Golmard, Chrystelle Colas

Summary: This study finds that monoallelic germline pathogenic variants in the MBD4 gene are associated with susceptibility to uveal melanoma and breast cancer among other cancer types. Further genetic testing and molecular tumor analyses are necessary to better understand the tumor spectrum and estimate the risk associated with this predisposition.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Biochemistry & Molecular Biology

Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial

Celine Callens, Manuel Rodrigues, Adrien Briaux, Eleonore Frouin, Alexandre Eeckhoutte, Eric Pujade-Lauraine, Victor Renault, Dominique Stoppa-Lyonnet, Ivan Bieche, Guillaume Bataillon, Lucie Karayan-Tapon, Tristan Rochelle, Florian Heitz, Sabrina Chiara Cecere, Maria Jesus Rubio Perez, Christoph Grimm, Trine Jakobi Nottrup, Nicoletta Colombo, Ignace Vergote, Kan Yonemori, Isabelle Ray-Coquard, Marc-Henri Stern, Tatiana Popova

Summary: The bevacizumab/olaparib maintenance regimen has been approved for first-line treatment of BRCA-mutated and HRD high-grade advanced ovarian cancer, based on the significantly improved progression-free survival compared to bevacizumab alone. In this study, a new test called shallowHRDv2 was developed as an alternative to MyChoice for HRD detection. The results show that shallowHRDv2 is a high-performing, clinically validated, and cost-effective test for HRD detection.

ONCOGENE (2023)

暂无数据